Company Investigates CooperVision

Finkelstein Thompson is investigating whether the CooperVision made misleading and false statements to the investing public by significantly increasing its guidance three times during the fiscal year 2011 in March, June and August 2011, all the while knowing that it had defects in certain of its contact lens product lines that would have a large impact on the company. The company is asking individuals who purchased shares of Cooper between March 4, 2011 and November 15, 2011, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at contact@finkelsteinthompson.com.